273 related articles for article (PubMed ID: 11180023)
1. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
2. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
3. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
[TBL] [Abstract][Full Text] [Related]
4. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
[TBL] [Abstract][Full Text] [Related]
5. Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.
Schwartz JI; Liu F; Stroh M; Gipson A; Johnson-Levonas AO; Lasseter KC; Lai E; Wagner JA
Am J Ther; 2009; 16(3):215-23. PubMed ID: 19454860
[TBL] [Abstract][Full Text] [Related]
6. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
[TBL] [Abstract][Full Text] [Related]
7. Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
Burstein AH; Clark DJ; O'Gorman M; Willavize SA; Brayman TG; Grover GS; Walsky RL; Obach RS; Faessel HM
J Clin Pharmacol; 2007 Nov; 47(11):1421-9. PubMed ID: 17962429
[TBL] [Abstract][Full Text] [Related]
8. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
[TBL] [Abstract][Full Text] [Related]
9. Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-state warfarin.
Kirby LC; Johnson BM; Adams LM; Eberwein DJ; Zhang K; Murray SC; Lates CD; Blum RA; Morris SR
J Clin Pharmacol; 2010 May; 50(5):566-75. PubMed ID: 20220045
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
12. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
Schwartz JI; Dunbar S; Yuan J; Li S; Gipson A; Rosko K; Johnson-Levonas AO; Lasseter KC; Addy C; Stoch AS; Wagner JA
Adv Ther; 2008 Nov; 25(11):1175-90. PubMed ID: 18989636
[TBL] [Abstract][Full Text] [Related]
13. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
Parra D; Beckey NP; Stevens GR
Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
[TBL] [Abstract][Full Text] [Related]
14. Absence of a pharmacokinetic interaction between etanercept and warfarin.
Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
[TBL] [Abstract][Full Text] [Related]
15. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
[TBL] [Abstract][Full Text] [Related]
16. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
McAleer SD; Foondun AS; Feely M; Chrystyn H
Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
[TBL] [Abstract][Full Text] [Related]
17. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
Guerret M; Francheteau P; Hubert M
Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
[TBL] [Abstract][Full Text] [Related]
19. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
[TBL] [Abstract][Full Text] [Related]
20. The effect of etoricoxib on the pharmacodynamics and pharmacokinetics of warfarin.
Schwartz JI; Agrawal NG; Hartford AH; Cote J; Hunt TL; Verbesselt R; Eckols DR; Gottesdiener KM
J Clin Pharmacol; 2007 May; 47(5):620-7. PubMed ID: 17442687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]